Europe Veterinary Point of Care Blood Gas Analyzer Market Analysis (2017-2023)
Special Offering : Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The Europe Veterinary Point of Care Blood Gas Analyzers Market would witness market growth of 4.5% CAGR during the forecast period (2017 - 2023). Veterinary blood gas analyzer are used in measuring pH levels, blood gases, electrolytes, and metabolites parameters in the blood specimen. These devices offer convenient testing options and also facilitate rapid diagnosis. Acid-base and respiratory issues are some of the common issues among hospitalized animals. Therefore, the blood gas analyzers have grown popular as diagnosing and monitoring tools.
Growing inclination towards owning companion animals, technological advancements in the blood gas analyzers, growing awareness about animal health, increasing expenditures on animal welfare are the factors that drive the growth of the veterinary point of care blood gas analyzers market. Based on modality, the market is segmented into Por TABLE Analyzers and Handheld Analyzers. Based on animal, the market is segmented into Companion Animals, Poultry & Dairy animals, Livestock Animals, and Others.
Based on the End user, the market is segmented into Veterinary Clinics, Veterinary Laboratories, Research Laboratories, and Others. The report also covers country wide segmentation of Veterinary Point of Care Blood Gas Analyzers market. The countries included in the report are Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stakeholders of the Europe Veterinary Point of Care Blood Gas Analyzers Market. Key companies profiled in the report Heska Corporation, Vepalabs, Nova Biomedical, LifeHealth, LLC, Abaxis, Inc., F. Hoffmann-La Roche AG, Bayer AG, Siemens Healthcare, OPTI Medical Systems Inc., and Radiometer Medical ApS